Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.20.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenues:    
Revenues $ 13,644,486 $ 10,679,376
Cost of Revenue [Abstract]    
Cost of revenues 1,486,155 1,205,941
Selling and marketing expenses 2,055,289 1,505,988
Depreciation and amortization 654,249 365,678
General and administrative expenses 8,694,250 6,552,904
Total selling, general and administrative expenses 11,403,788 8,424,570
Net loss on disposition or impairment 1,193 105,193
Income from operations 753,350 943,672
Other (expense) income:    
Bargain purchase gain 0 19,298
Other expense, net 4,337 11,645
Total other (expense) income (4,337) 7,653
Income before income tax benefit 749,013 951,325
Income tax benefit (65,934) (1,319)
Net income and comprehensive income 814,947 952,644
Less: income attributable to the non-controlling interest 0 0
Net income attributable to The Joint Corp. stockholders $ 814,947 $ 952,644
Earnings per share:    
Basic earnings per share (in dollars per share) $ 0.06 $ 0.07
Diluted earnings per share (in dollars per share) $ 0.06 $ 0.07
Basic weighted average shares (in shares) 13,890,673 13,751,196
Diluted weighted average shares (in shares) 14,483,584 14,256,006
Revenues from company-owned or managed clinics    
Revenues:    
Revenues $ 7,294,295 $ 5,639,076
Royalty fees    
Revenues:    
Revenues 3,718,230 3,026,815
Franchise fees/Franchise and regional development cost of revenues    
Revenues:    
Revenues 512,751 417,073
Cost of Revenue [Abstract]    
Cost of revenues 1,417,491 1,117,053
Advertising fund revenue    
Revenues:    
Revenues 1,057,618 891,567
Software fees/IT cost of revenues    
Revenues:    
Revenues 645,725 365,236
Cost of Revenue [Abstract]    
Cost of revenues 68,664 88,888
Regional developer fees    
Revenues:    
Revenues 207,642 183,858
Other revenues    
Revenues:    
Revenues $ 208,225 $ 155,751